Role of SCF/c-KIT axis in pericyte TNT-guided vessel branching Authors: Daniela Virgintino, Antonio d’Amati, Tiziana Annese, Michelina De Giorgis, Antonella Bizzoca, Ignazio de Trizio, Thomas Wälchli, Marianna Sgarlata, Ramani Ramchandran, Roberto Perris, Francesco Girolamo, Mariella Errede Published: 2026 ABSTRACT AbstractBackgroundIn the developing human brain, forebrain pericytes of neural crest origin are proposed to exert their function at the leading front of growing vessels. The combined sprouts are made up by an endothelial tip cell and a more advanced pericyte extended tunnelling nanotube (TNT), which forms ‘intervascular bridges’ during vessel branching. To better understand of the process of pericyte TNTs (P-TNTs)-guided vessel growth, we have immunolocalized the c-KIT (CD117) receptor and its ligand SCF, as a possible ‘non canonical’ signaling pathway involved in endothelium-pericyte interactions during the pericyte-driven mode of sprouting.MethodsImmunofluorescent high-resolution confocal microscopy and 3D modelling were applied on human developing brain and glioblastoma (GB) sections. TNTs were revealed by sequential scanning of 20-µm tissue sections, leveraging on NG2 proteoglycan as a marker of immature/re-activated pericytes and on collagen type IV (COL IV) as a TNT-associated ECM molecule. Confocal-aided morphometry was applied to evaluate the density of NG2+ TNTs on brain and tumor vascular networks. The cellular and subcellular immunolocalization of c-KIT and SCF was achieved by double staining with NG2 and the endothelial cell-marker CD31.ResultsIn both developing brain and GB samples, P-TNTs are seen associated with pericytes budding from parental vessels or advancing at the distal edge of combined vessel sprouts. The number of TNTs largely prevails in fetal brain, compared with peripheral GB areas, while it significantly reduces in tumor core areas. c-KIT+/SCF+ endothelial cells lie close to c-KIT−/SCF+ pericytes in both fetal and tumor samples. In endothelial cells of fetal brain microvessels, c-KIT shows a dual cell membrane and nuclear localization, the latter being barely detectable on endothelial cells of tumor vessels.ConclusionsP-TNTs, which are tightly associated in situ with endothelial–pericyte combined sprouts, appear to play a dual role during vessel collateralization by bridging the gap between distant vessels and guiding vascular outgrowth. The complementary cellular distribution of c-KIT and SCF observed in endothelial cells and pericytes suggests that both endothelial autocrine/paracrine SCF/c-KIT signaling and pericyte-derived paracrine/juxtacrine SCF cues may contribute to the pericyte-driven mode of vessel branching. Similar observations in GB samples further suggest a potential involvement of pericytes and their P-TNTs in tumor vascularization, although sprouting endothelial cells displayed distinct subcellular patterns of c-KIT expression in fetal versus GB tissues.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12987-026-00827-0.Keywords: Pericytes, Tunnelling nanotubes, c-KIT, SCF, Angiogenesis, Human fetal brain, Glioblastoma Background Pillars of the proposed P-TNT-guided mode of vessel growth Neovascularization in developing human brain remains a poorly studied phenomenon because of ethical concerns, the difficulty in accessing suitable study material, and the legal restrictions imposed on the reproduction of human embryos from embryonic stem cells or iPS cells. Investigations are therefore delimited to the more thorough description of the morphological and cellular features of the process and the spatial mapping of putative molecular actors in situ. Interestingly, developmental signaling and pathways shares many traits with that taking place in cancer cells and their microenvironment, suggesting that an onco-fetal axis may also intervene in hypervascularized gliomas reprogramming aberrant fetal angiogenic programs [1–6]. We and other groups have previously documented the active role of brain pericytes in the structuring of brain neovessels; a role accounted by the guidance of the endothelial cells shaping the angiogenic sprouts [1, 7–10]. In both syngeneic/mutant and xenografted mouse models, it has been demonstrated that immature/re-activated pericytes orchestrate the angiogenic sprouting by creating scaffolds for the migrating endothelial cells of nascent vessels [11, 12]. The role of pericytes in the early phases of neuro-angiogenesis is further substantiated by the documented formation of endothelium-free pericyte conduits of growing sprouts in experimentally induced angiogenesis in mouse retina, murine glioma models [11, 12], human brain development, and glioblastomas [8, 13–17]. An important pillar of the understanding of the role of TNTs during pericyte-driven neuro-angiogenesis lies in the pioneering electron microscopy studies carried out during human brain vascularization. Pericytes of hypoxic brains are described as provided of long processes, whose distal end enters in contact with a distant vessel [18]. These TNT-like pericyte extensions being also associated with pericyte conduits enwrapped by a vessel basal lamina and inhabited by isolated processes of endothelial cells [19]. It has been suggested that dependent on their ontogenic origin, brain pericytes may differently contribute to angiogenesis, undergoing an early recruitment and extending up, although not ahead, of the endothelial tip cell [20, 21]. In contrast, in developing human brain, pericytes may even lie at the advancing edge of the growing vessel, where they seem to endeavor a sprout-guiding function through the extension of tunnelling nanotubes (TNTs) [8, 14, 15]. The dual ontogeny of brain pericytes refers to their mesenchymal and ectomesenchymal phenotypes, the former associated with mesoderm-derived mesenchymal stem cells (midbrain and hindbrain pericytes), the latter with neuroectoderm-derived neural crest cells (NCCs) (forebrain pericytes) [22, 23]. The subset of forebrain NCC-derived pericytes displays NCC-specific genes, such as FOXF2, and high levels of mesenchymality, together with a robust expression of pericyte-specific markers, such as PDGFRβ, NG2, CD13, and CD146 [24, 25]. Notably, the analysis, by cross-species scRNA-seq and whole-genome DNA methylation, of molecular relationships between embryonic cranial NCCs and cranial NCC-derived ectomesenchyme cell pools, has established that the latter retain a unique pluripotency signature, including genes of the epithelial-mesenchymal transition [26], hence it could be speculated that also the attitude of forebrain pericytes of emanating TNTs may reflect their NCC-derived phenotype [22, 23, 27–32] and the ability of neuroectoderm-derived cells in communicating via TNTs [27–29, 31]. Pericyte TNTs (P-TNTs) are assigned to the multifaced family of nanostructures, generally described as 50–1000 nm in width and > 300 μm in length, cabling remote cell-to-cell communications in pathophysiological processes, brain development as well as neurodegenerative diseases and brain cancer [33–37]. It is conceivable that in forebrain derivatives, such as cerebral hemispheres and retina, P-TNTs on account of their common origin from NCCs, can be skilled to emanate TNTs and intervene in neuroangiogenesis and in neurovascular coupling, as well as in cell-cell crosstalk within the neurovascular unit [8, 15, 34, 35, 38–41]. Mechanistic analysis of the P-TNT-guided mode of vessel growth It is highly likely that mechanisms distinct from those driven by canonical pro-angiogenic molecules contribute to what appears to be direct control exerted by pericytes over vascular sprouting. Given these considerations, we focused on the c-KIT/CD117 tyrosine kinase (TK) receptor and its ligand SCF (stem cell factor) as potential non-canonical regulators of vascular sprouting. The c-KIT/SCF axis, which plays a crucial role in cell survival, proliferation, and chemotaxis, also exhibit specific pro-angiogenic activity on endothelial cells during vascular development [42–46], as well as in pathological neovascularization associated with ischemia, cancer, and retinal diseases [47–50]. Both endothelial progenitor cells and human umbilical vein endothelial cells (HUVECs) express high levels of c-KIT. In HUVECs, SCF-mediated c-KIT self-activation promotes cell survival, migration, and capillary tube formation in a manner comparable to VEGF responses [51, 52]. Against this background, we aimed to investigate the potential role of SCF/c-KIT pro-angiogenic signaling associated with pericyte-driven, P-TNT-guided mode of vessel growth, by examining the cellular and subcellular distribution of c-KIT and SCF in endothelial cells and pericytes tightly associated within fetal brain and glioblastoma (GB) combined vessel sprouts. Methods Ethical approvals The sampling and handling of fetal human specimens conformed to the ethical rules of the Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, and approval was gained from the local Ethics Committee of the National Health System in compliance with the principles stated in the Declaration of Helsinki. Fetal tissue was collected after obtaining informed consent from the mother at the end of the abortion procedure. For glioblastoma specimens, written informed consent was obtained from patients who underwent surgery at the Department of Neurosurgery, University Hospital Zurich (Switzerland), before study entry. All procedures were approved by the Ethics Committee of the University of Bari Medical School and by the Ethics Committee of Canton Zurich, in accordance with the Declaration of Helsinki. Histological and immunohistochemical analyses of fetal brain Fetal brain specimens were dissected from fetuses at 18 (n = 2) and 22 (n = 2) weeks of gestation (wg), spontaneously aborted and with no history of neurological pathologies. The fetal age was estimated based on the crown-rump length and/or pregnancy records (counting from the last menstrual period). At autopsy, the fetuses did not reveal macroscopic structural abnormalities and/or malformations of the central nervous system. The dorsolateral wall of the telencephalic vesicles (future cerebral cortex) was dissected, along the coronal planes, in slices (n = 6/fetus) about 0.5 cm thick, fixed for 2–3 h at 4 °C by immersion in 2% paraformaldehyde (PFA) plus 0.2% glutaraldehyde (GTA) in phosphate-buffered saline solution (PBS, pH 7.6) and then washed in PBS. Slices were serially cut, using a vibrating microtome (Leica Microsystem), into ∼30-µm-thick sections, parts of which were processed for routine histological analysis with toluidine blue staining to rule out the presence of microscopic malformations. All the other sections were stored at 4 °C in PBS plus 0.02% PFA for immunofluorescence confocal microscopy. Double immunostainings were carried out using the following polyclonal (pAb) and monoclonal (mAb) antibodies diluted in blocking buffer (BB; 1% bovine serum albumin and 2% fetal calf serum in PBS): rabbit pAb anti-NG2 (1:50 dilution), directed against the rod-like subdomain (D2) of the extracellular NG2 domain (for details see: [13, 53]); mouse mAb anti-NG2 hybridoma clone 2161F9 (undiluted supernatant; see [1]); mouse mAb anti-CD31 (1:10 dilution; Dako, Cat. M0823); mouse mAb anti-collagen type IV (1:100 dilution; Dako, Cat. M0785); rabbit pAb anti-collagen type IV (1:100 dilution; OriGene Technologies GmbH, Cat. R1038X); rabbit pAb anti-c-KIT/CD117 (1:100 dilution; Agilent Dako, Cat. A4502); and rabbit pAb anti-SCF (1:100 dilution; Abcam, Cat. ab64677). Free-floating sections were incubated with 0.5% Triton X-100 in PBS for 30 min at room temperature (RT), BB 30 min at RT, followed by incubation, with combined primary antibodies, overnight at 4 °C and with appropriate fluorophore-conjugated secondary antibodies (Alexa Fluor™ 488 and 555; Thermo Fisher Scientific) or biotinylated secondary antibodies for 45 min at RT, the latter revealed by fluorophore-conjugated streptavidin (Streptavidin-Alexa Fluor™ 488, Streptavidin-Alexa Fluor™ 555; Thermo Fisher Scientific). In double immunostaining with NG2, CD31, and collagen IV c-KIT and SCF immunosignals were amplified by streptavidin-biotin system. After each incubation step the sections were rinsed 3 × 5 min with PBS. Nuclear counterstaining was performed with TO-PRO-3 diluted 1:10 K in PBS (Thermo Fisher Scientific). Finally, the sections were allowed to adhere to polylysine slides (Menzel-Glaser) by drying for 10 min at RT, coverslipped with Vectashield (Vector Laboratories) and sealed with nail varnish. Negative controls were prepared by omitting and mismatching the primary and secondary antibodies. Histological and immunohistochemical analyses of glioblastoma lesions Glioblastoma samples (n = 6) were collected from primary tumors specimens obtained in a previous study, in which the imaging techniques and histological analysis were specified in detail [33]. The six glioblastoma patients were 4 males, aged 30 to 55 years, and 2 females, aged 52 and 53 years, who underwent surgery at the Department of Neurosurgery, University Hospital Zurich (Switzerland). Glioma samples were classified according to the WHO 2021 criteria. The samples were dissected (≤ 0.5 cm in thickness) and then fixed for 2–3 h at 4 °C by immersion in 2% PFA plus 0.2% GTA in PBS (pH 7.6). Specimens were then washed in PBS and serially cut using a vibrating microtome (Leica Microsystem); 30-µm sections were stored at 4 °C in PBS plus 0.02% PFA for immunofluorescence confocal microscopy. Double immunostaining with c-KIT combined with collagen IV and NG2 and with SCF combined with CD31 and NG2, as well as negative controls were performed as described in the section above. High-resolution confocal microscopy analyses Fetal brain and glioblastoma sections were examined with a Leica TCS SP8 confocal laser-scanning microscope (Leica Microsystems). Cellular and subcellular observations were carried out at a higher resolution on single z-slices (confocal optical sections), using a 63x oil lens and additional zoom factors from 1.5 to 3. 3D modeling of TNTs resulted by the analysis of their extension from their proximal origin to the more distal detectable end, in the entire section volume (∼ 0.75 mm3), on z-stacks (projection images), at 40x magnification. Morphometry and quantitative analyses The quantitative analysis assessed two morphometry parameters: (1) cumulative vessel length (CVL, expressed in µm of vessel length)/area in mm2) and (2) TNT density (number of identified TNTs/CVL). These quantifications were performed by FG, unaware of the group designations, using computer-aided morphometry on confocal microscopy images from NG2-stained sections, and analyzed with the analyze functions of ImageJ (NIH, Bethesda, U.S.). Randomly chosen fields (12 per section; n = 3 sections) were acquired from fetal (n = 3), glioblastoma core (n = 3), and glioblastoma periphery (resection margins; n = 3) samples. The selected parameters were measured on confocal images acquired using 40x and 63x oil lenses (area 150,156 µm2 and 60,516 µm2, respectively, at 0.24 μm per pixel) and visualized as single-channel z-stack projections of 18 z-slices. Statistical analysis The collected morphometry data were statistically analyzed using one-way ANOVA and the Bonferroni post-test (GraphPad Prism, GraphPad Software, Inc.) and expressed as mean value ± standard deviation (M ± SD). A mixed linear model regression analysis was performed on CVL by writing and running a Python code and declaring specific patients as random factors. p < 0.05 was set as the limit for statistical significance. Results Delineation of the pericyte-driven TNT-guided mode of vessel growth Double staining with the pericyte-specific marker NG2 and the endothelial marker CD31, performed on fetal brain sections, reveals the presence at sites of microvessel branching, the presence of CD31+/NG2+ endothelium-pericyte combined sprouts, as well as their association with NG2+ pericyte TNTs (P-TNTs) (Fig. 1A-D). TNT-bearing pericytes are positioned ahead of the sprouting conduit and enwrap CD31+ endothelial cells, at various stages of their advancement and lumen formation (Fig. 1A-D). During the earliest phases of this process, endothelial tip cells may be observed within the proximal tract of the nascent vessel, showing typical multiple filopodia and releasing CD31+ microvesicles [54] (Fig. 1A). Subsequently, vessel elongation involves endothelial stalk cells that line the nascent vessel and, together with the endothelial tip cells, generate membrane blebbing and start to form the vessel lumen [55] (Fig. 1A, B). During the entire process, the leading pericyte extends a long TNT at the distal end of the growing sprout (Fig. 1B). The described mutual endothelium-pericyte interactions observed here and in previous studies in developing human brain [8, 13, 15] allow us to outline the steps followed in this mode of vessel growth: (i) pericyte budding from the parental vessel, (ii) TNT extension from the leading pericyte, (iii) endothelial sliding within the pericyte conduit, (iv) elongation and lumenization of the TNT-guided sprout (Fig. 1C, D; an additional figure showing step (iii) in a closer sequence has been included as Additional file 1). At sites of vessel collateralization and intervascular bridge formation, features consistent with vessel regression/pruning were only rarely observed and were characterized by a disorganized and loose basal lamina associated with fragmented endothelial cells lining the lumen of vascular ghosts (see Additional file 2 and compare with Additional file 1; see for a review: [56]). Representative confocal images of endothelial-pericyte combined sprouts formed by NG2+ pericytes, NG2+ P-TNTs, and CD31+ endothelial cells. A The combined sprout in an early phase of its growth shows the leading pericyte (P), the endothelial tip cell engaged in the proximal tract of the pericyte conduit (E), its typical filopodia (arrowhead), together with endothelial membrane blebbing observed during vessel lumen formation (yellow arrow); note the presence of endothelial CD31+ microvesicles (arrows) inside the distal pericyte conduit. B A NG2+ P-TNT emerges from the leading pericyte (P1), which lies ahead of the tip endothelial cell (E); a second NG2+ pericyte (P2) ensheathes CD31+ stalk endothelial cells (arrowheads) that line the elongated pericyte conduit and form the vessel lumen (yellow arrows), also recognizable in the cross section (inset, yellow arrow). C A combined endothelial-pericyte sprout and its schematic illustration (D), showing sprout structure and composition: the leading pericyte (P), the frontmost endothelial cell (E), the forming vessel lumen (here occupied by a red blood cell, asterisk), and the associated P-TNT. N, nucleus; P-TNT, pericyte tunneling nanotube. Nuclear counterstaining TO-PRO-3. Scale bars A 10 μm; B, C 15 μm Confocal-aided morphometric analysis of microvessel networks and P-TNTs To compare the extent of developing and tumoral vascular networks and evaluate the frequency of P-TNTs in these conditions, fetal brain and GB sections, immunostained for the pericyte-specific marker NG2, were analysed by confocal microscopy-assisted morphometry. The vascular network extension was evaluated according to their cumulative vessel length (CVL; µm/mm2) and the obtained data were compared with the counted number of P-TNTs to obtain the parameter of their density per vascular network. The results show that the GB vascular bed expressed as CVL doubles the vascular networks of both peritumoral areas and developing cerebral hemispheres, even though the differences are not statistically significant (fetal brain = 3606 ± 180; glioblastoma core areas = 7469 ± 5020.0; and tumor periphery areas = 3538 ± 2057; p = 0.75) (Fig. 2A). Bar graphs show the comparison of the NG2+ CVL and the density of NG2+ P-TNT/CVL between fetal brain, tumor periphery and tumor core tissues. (A) Quantification of the CVL shows no difference between the extent of the vessel network in the three tissue groups, mainly due to the marked glioblastoma heterogeneity. (B) Quantification of the NG2+ TNT/CVL density shows significantly more NG2+ P-TNT in fetal brain than in the glioma lesions (**: p = 0.8) Nonetheless, the data obtained on P-TNT density confirm that in fetal brain at mid-gestation the penetrating stem vessels are building up a second capillary plexus in the intermediate zone of the cerebral hemispheres [57] and suggest that P-TNT can play a primary role in the process. In fact, density of NG2+ pericyte-associated TNTs appears significantly higher in fetal brain (0.096 ± 0.021) compared to both glioblastoma core and tumor periphery (0.021 ± 0.0039 and 0.0018 ± 0.0031, respectively; p = 0,008) (Fig. 2B). It is worth noting that the value of TNT density at the tumor periphery, where sprouting microvascular proliferations prevail, is higher compared with tumor core areas, where a variety of microvascular proliferations formed by aberrant angiogenesis are recognizable (Fig. 2B). Detection of c-KIT immunosignal in fetal brain and glioblastoma microvessels as revealed by collagen type IV To visualize the extent of the vascular networks in fetal brain and GB - including both combined sprout profiles and P-TNTs – and to detect cellular and subcellular c-KIT immunoreactivity, we employed double immunostaining for c-KIT and COL IV. COL IV is a major molecular component of the extracellular matrix (ECM) that forms the vessel basal lamina and is also a constituent of the ECM associated with P-TNT. By delineating even the thinnest and most distal P-TNT segments, COL IV can indirectly interact with the large extracellular domain of NG2 chondroitin sulfate proteoglycan 4 (CSPG4), which mediates cell-substratum interactions and cell spreading [58–61]. On fetal brain sections, neural progenitors form a c-KIT+ background, displaying a c-KIT nuclear reactivity (Fig. 3A-F) and c-KIT+ staining of their processes (Fig. 3C). Representative confocal z-stack projection images (A-D) and single z-slices (E, F) of fetal brain sections double immunostained for c-KIT and collagen IV (COL IV). A On the background of c-KIT+ neural progenitor cells, COL IV reactivity underlines c-KIT immunoreactive microvessels (V) and their c-KIT+ endothelial lining (arrowheads); a pericyte-like conduit (P) ending distally in a TNT (P-TNT). B A combined sprout (arrow) formed by two c-KIT+ endothelial cells (arrowheads) and a c-KIT− leading pericyte (P1), positioned on the tip region of the combined sprout and sending its TNT (P-TNT1) toward the opposing vessel (V) that shows a c-KIT− budding pericyte (P2) that also emanates a short TNT (P-TNT2), captured during the merging process; note in the upper right corner a c-KIT− microvessel (asterisk). C A typical COL IV+ P-TNT intervascular bridge with a pre-engaged c-KIT+ endothelial cell (yellow arrow); notable is also the concurrent c-KIT staining of nucleus (white arrow) and leading process (arrowhead) of a migrating neuronal precursor. D A c-KIT− pericyte (white arrow) at the leading edge of a pericyte conduit (P) connected with the parental vessel, which is marked by a KIT+ endothelial cell (yellow arrow). E, F Single z-slices better show the subcellular distribution of endothelial c-KIT on longitudinally sectioned microvessels (V), recognizable as a strong nuclear reactivity (arrows) and a linear and continuous staining pattern, possibly associated with the cell surface (arrowheads). Nuclear counterstaining TO-PRO-3. Scale bars A, B 25 μm; C, D, F 10 μm; E 15 μm Not all microvessels are c-KIT+ (Fig. 3B). Those that are positive are often associated with P-TNT-guided vessel sprouts (Fig. 3A, B, D), as well as with intervascular bridges formed by P-TNT (Fig. 3C). Cellular and subcellular immunolocalization of c-KIT shows c-KIT− leading pericytes and c-KIT+ endothelial cells (Fig. 3B, D). Endothelial cells show dual c-KIT immunoreactivity, identified as nuclear and cytoplasm immunosignals (Fig. 3A-D). Moreover, the analysis of subcellular c-KIT distribution in single confocal slices allows to detect a linear and continuous c-KIT signal, resulting from the possible association of the receptor with the endothelial plasma membrane (Fig. 3E, F). According to these results it can be suggested that in fetal brain, c-KIT+ endothelial cells are restricted to growing segments and/or branching points of the microvascular network. In tissue sections obtained from GB peripheral areas, several tumor microvessels, of regular caliber and cell structure, show a week or absent c-KIT immunoreactivity (Fig. 4A, C). Representative confocal images of glioblastoma sections double immunostained for c-KIT and COL IV. A Tumor vessels and TNTs, as revealed by their COL IV-associated extracellular matrix, on a background of c-KIT+ tumor cells, with c-KIT+ nuclei and processes (arrowhead). B A COL IV+ P-TNT-like intervascular bridge (TNT) connecting two tumor microvessels showing c-KIT+ endothelial cells; at a subcellular level, endothelial cells lack nuclear c-KIT (double arrows), while showing a diffuse cytoplasm expression of the receptor (yellow arrowheads); note the nuclear and cytoplasmic c-KIT immunoreactivity of a tumoral cell (white arrowhead). C. A weakly stained tumor microvessels with a very weak c-KIT reactivity of the endothelial cytoplasm (arrow) and a c-KIT− nucleus c-KIT− (double arrows); the pericyte nucleus also does not stain for c-KIT (arrow); note what seems the proximal tract of two P-TNT-like cell processes (TNT). D Tumor cells exhibit a diffuse c-KIT reactivity both on the nucleus and cytoplasm (arrowheads); a tumor microvessel showing a budding pericyte (arrow) that emanates its TNT (TNT), which bridges the gap between two distant vessels; the nucleus of the endothelial cell beneath the pericyte does not show any detectable c-KIT staining (double arrow). Nuclear counterstaining TO-PRO-3. Scale bars A 25 μm; B, 15 μm; C, D 10 μm c-KIT+ microvessels are often only those associated with P-TNT-guided sprouts and P-TNT-like intervascular bridges (Fig. 4B, D). At a cellular and subcellular level, as already observed in fetal brain, microvessels show c-KIT− pericytes and c-KIT+ endothelial cells (Fig. 4B, D), whereas at a subcellular level, unlike the dual immunolocalization of c-KIT observed on fetal endothelial cells, tumoral endothelia are characterized by a virtually absent c-KIT nuclear staining and a scattered cytoplasmic reactivity (Fig. 4B, D). According to these results, and in consideration of the observed differential subcellular distribution of c-KIT, it can be suggested that the TK c-KIT receptor may play distinct, tissue-specific roles during fetal brain and GB microvessel growth. Our previous analyses of classical vessel sprouts, carried out with endothelium-specific markers together with COL IV were unable to detect endothelium-associated TNTs; only CD31+/COL IV− TNT-like long filopodia were detected among the shorter processes that characterize the endothelial tip cell [8]. Actually, formation of TNTs can be induced in endothelial cells in vitro and in vivo [62], nonetheless, pericytes seem to be more active in generating TNTs than endothelial cells [15], the latter being effective in communicating over long distances via secretory granules and extracellular vesicles [54, 63]. Detection of c-KIT immunosignal in fetal brain and glioblastoma microvessels as revealed by the pericyte-specific marker NG2 In human fetal brain, NG2 proteoglycan delineates the cell body and processes of pericytes that cover the wall of growing microvessels (Fig. 5A-C). Representative confocal images of fetal brain sections double immunostained for c-KIT and NG2 proteoglycan, showing the microvessel coverage formed by NG2+ pericytes and NG2+ pericyte-derived TNTs (P-TNT), together with c-KIT+ endothelial cells. A On the parental microvessel, a NG2+c-KIT− pericyte (white arrow) lies close to a pre-engaged c-KIT+ endothelial cell (yellow arrow) and extends a long TNT forming an intervascular bridge (double arrowhead). B The higher magnification of the microvessel in ‘A’, at the site of a pericyte conduit, shows the NG2+c-KIT− pericyte (white arrows), the pre-engaged c-KIT+ endothelial cell (yellow arrows), and the proximal tract of the NG2+ P-TNT; note the NG2+c-KIT− pericyte on the parental vessel (arrowhead). C On the left side of a parental microvessel, two points of vessel branching are recognizable as marked by NG2+ P-TNT, NG2+/c-KIT− pericytes (white arrow), and pre-engaged c-KIT+ endothelial cells (yellow arrow); note on the right side an NG2+c-KIT− budding pericyte (arrowhead). Nuclear counterstaining TO-PRO-3. Scale bars A, C 25 μm; B 10 μm The pericyte origin of TNTs is confirmed by NG2 immunostaining showing pericytes and their P-TNTs that form intervascular bridges and originate at regular intervals from the parental vessel (Fig. 5A-C). As already described on c-KIT/COL IV-stained sections, c-KIT immunosignal is detectable on the nucleus and cytoplasm/plasma membrane of endothelial cells engaged in the nascent sprout (Fig. 5A-C), whereas pericytes show no evidence of c-KIT immunoreactivity (Fig. 5A-C). In GB peripheral areas, pericytes, which in adult normal brain do not express the NG2 proteoglycan, become activated and re-express NG2, similar to immature, fetal brain pericytes [1]. Analysis of c-KIT/NG2 double stained sections from GB samples confirms a strong c-KIT nuclear and cytoplasmic staining of tumor cells (Fig. 6A-C). Representative confocal images of glioblastoma sections double immunostained for c-KIT and NG2 proteoglycan, showing tumor microvessels with an NG2+ pericyte coverage and c-KIT+ endothelial cells. A On the c-KIT+ tumor cell background, an NG2+c-KIT− pericyte is recognizable (white arrow) at the proximal side of a pericyte conduit (yellow arrow); on the left side a P-TNT spans a short distance to connect two tumor microvessels. B The higher magnification of the microvessels depicted in ‘A’, centered on the NG2+ P-TNT, tumor endothelial cells with a weak nuclear c-KIT staining (arrowheads) and a sparse cytoplasmic reactivity for the receptor (arrows). C A short NG2+ P-TNT bridges two c-KIT+ tumor microvessels; the endothelial c-KIT nuclear staining is barely detectable (arrowhead), while c-KIT stains the endothelial cytoplasm (arrows). Nuclear counterstaining TO-PRO-3. Scale bars A 25 μm; B, C 10 μm Tumor microvessels display an extensive NG2+ pericyte coverage from where NG2+ P-TNTs arise and form intervascular bridges (Fig. 6A-C). A low c-KIT immunosignal is detected on endothelial cell nuclei together with a scattered cytoplasmic immunoreactivity (Fig. 6A-C). Detection of SCF immunosignal in fetal brain and glioblastoma microvessels as revealed by CD31 and NG2 Immunolocalization of c-KIT receptor on endothelial cells opened the way to the investigation of its ligand SCF at the level of both fetal brain and GB microvessels, in double staining with the endothelial marker CD31 and NG2 as a specific marker of immature/re-activated pericytes (Figs. 7 and 8). Representative confocal images of fetal brain sections double immunostained for SCF and CD31 (A, B) and SCF/NG2 (C, D). A CD31+ endothelial cells of a fetal brain microvessel (V) showing large patches of cytoplasmic SCF reactivity (arrow), together with a fine and linear SCF labeling aligned with the junctional CD31 pattern at the basolateral cell membrane (arrowhead); note an SCF+ pericyte-like mural cell (yellow arrow) and SCF+ neuronal precursors in the background (asterisks). B Large patches of SCF cytoplasmic staining (arrow) in the CD31+ endothelium of a fetal brain microvessel (V); on the opposite vessel wall, an SCF fine and linear staining marks the basolateral, CD31+ endothelial membrane (arrowheads); the latter, an enlarged view shows points of SCF/CD31 colocalization, suggesting the binding of SCF to c-KIT receptor on the endothelial membrane (inset, x2; arrows). C Typical NG2+ P-TNTs at the advancing front of two SCF+ combined vessel sprouts (arrows). D A combined sprout (arrowhead), formed by the NG2+/SCF+ leading pericyte (white arrow) and the SCF+ engaged endothelial cell (yellow arrow), the associated P-TNT forms an intervascular bridge, that merges with an opposite NG2+ sprout; an enlarged view of the leading pericyte shows patches of SCF immunoreactivity in the pericyte cytoplasm (inset, x4; arrows). Nuclear counterstaining TO-PRO-3. Scale bars A, B, D 10 μm, C 25 μm Representative confocal images of glioblastoma sections double immunostained for SCF and CD31 (A, B) and for SCF and NG2 (C, D). A A CD31+ capillary-like microvessel (V) of the tumor peripheral areas shows a delicate endothelial SCF staining pattern that matches the CD31 basolateral staining (arrows). B In the glioblastoma core, the endothelial cells of a typical microvascular proliferation show loss of junctional CD31 and a diffuse cytoplasmic CD31staining and large SCF+, cytoplasmic patches (white arrows); note a SCF+ pericyte-like mural cell (yellow arrow). C, D Two NG2+/SCF+ parental microvessels (V), give rise to combined sprouts captured at the earliest phases of their development; in ‘C’ a conduit formed by the NG2+/SCF+ budding pericyte (arrowhead), while in ‘D’ the NG2+/SCF+ pericytes (arrowhead) is more advanced along the conduit and precedes an SCF+ pre-engaged endothelial cell (arrow); note SCF+ giant glioblastoma cells in the background (asterisks). Nuclear counterstaining TO-PRO-3. Scale bars A, B, C, D 10 μm On fetal brain sections, SCF is immunolocalized on endothelial cell cytoplasm and appears also aligned with endothelial CD31 staining at the endothelial basolateral membranes, thus suggesting the presence of the ligand at the abluminal endothelial surface (Fig. 7A, B). The subcellular analysis of SCF immunolocalization shows large cytoplasmic SCF-reactive patches (Fig. 7A, B) and reveals a fine, continuous and regularly distributed staining pattern, associated with the endothelial abluminal membrane (Fig. 7B). On brain sections double stained with SCF and NG2, the latter highlights endothelial-pericyte combined sprouts and P-TNTs (Fig. 7C, D). SCF is localized on the cytoplasm of leading pericytes also associated with P-TNT intervascular bridges (Fig. 7C, D). As revealed by comparing detailed images of endothelium and pericyte SCF reactivity, in the latter the c-KIT ligand is always revealed at the cytoplasmic level, whereas in endothelial cells it appears associated with the cell membrane (please compare insets in panel B and C of Fig. 7). The same cell-type distribution of SCF on endothelial cells and pericytes is observed on GB sections, although with different levels of expression (Fig. 8A-D). Capillary-like microvessels at the tumor periphery reveal a linear but discontinuous SCF immunostaining of CD31+ endothelial cells at their basolateral surfaces (Fig. 8A), whereas more typical tumor vessels within the tumor core are characterized by large patches of SCF staining (Fig. 8B). Capillary-like peripheral vessels, forming typical pericyte conduits and intervascular bridges, reveal a higher cytoplasmic expression of SCF in the involved pericytes, as well as on the parental vessel endothelial cells (Fig. 8C, D). High levels of SCF are also detected in several tumor cells (Fig. 8C, D). Discussion Morphological insights into the P-TNT-guided mode of vessel growth As revealed by morphometric analysis of P-TNT density, combined sprouts and TNTs are readily recognizable in the human fetal brain as well as in GB core and peripheral areas. In the latter, P-TNTs appears less prominent compared to fetal brain, and further reduces in GB core, despite the extensive vascularization typical of this area. It is worth noting, that GB periphery is characterized by “microvascular sprouting”, consisting of delicate capillary-like vessels resembling those observed in classic angiogenesis, whereas the tumor core is dominated by microvascular proliferations, such as vascular garland, vessel clusters, and glomeruloid vessels, often surrounding necrotic area and displaying altered vascular cell phenotypes [64, 65]. In the human fetal brain, P-TNTs associated with vessel sprouting are evident by midgestation, when a second capillary plexus forms between the developing cerebral cortex and the deeper periventricular plexus [57, 66]. At this stage, direction, radius, and branching angles of daughter vessels are engineered to parallel the nascent neuronal architecture, ensuring a spatially precise feeding [57, 66, 67]. The significant differences that may arise in neurovascular organization between primates and rodents underscore the relevance of human data on the development of tree-like and network-like vascular structures [57, 67], the latter being in contrast with the development of tree-like stem microvessels, produced via the classical “two-phase” model of VEGF-driven endothelial sprouting. A similar mode of capillary network construction is observed in the developing retina [68]. A recent study shows that retinal pericyte TNTs form in response to endothelial platelet-derived growth factor (PDGF) and participate in pericyte-to-endothelial communication [32]. Moreover, interpericyte TNTs have been described in retinal capillary plexuses, reaching the higher density and maximized extension in the human macula, where they are involved in neuro-vascular coupling [41, 69–73]. Overall, these findings suggest that also the geometric scheme of the retinal vascular network - engendered by the tissue precise cytoarchitecture - may serve as an informative model for future studies on the angiogenic role of pericyte TNTs in instructing microvascular branch orientation and docking. The ability of forebrain pericytes in both cerebral hemispheres and retinas to emanate TNTs that guide ‘lateral’ vessel growth may be related to their common putative origin from NCCs. This hypothesis is further supported by the pioneering studies on whole-mount samples of rat mesentery, where pericytes are described as positioned “at and in front of the advancing tips of endothelial sprouts” [74]. Although these observations do not contradict the classical model in which pericytes “extend up to but not ahead of the endothelial tip cell” [20, 21], they suggest that distinct modes of vascular sprouting may coexist within developing microvascular networks. In the Nehls and collaborators’ study – published well before the first formal description of TNTs [75] - pericytes were depicted as slender, bipolar cells with processes extending up to 100 μm distances and bridging opposing vessels or merging vascular sprouts [74]. The authors hypothesized that such pericyte processes may provide guiding structures for the outgrowth of endothelial cells and might explain how “capillary sprouts find each other” to establish capillary beds [15, 74]. The shared involvement of NCC-derived pericytes in cerebral, retinal, and mesenteric vascular networks is further supported by studies showing that cranial NCCs rely long ‘filopodia’ – extending up to 100 μm – to maintain interactions with their neighboring and non-neighboring cells, thus providing directional cues and pathfinding functions [27]. The described filopodial processes strikingly resembling the description of long cell-to-cell strands called tunnelling nanotubes and published in the same year [75]. More recently, the angiogenic “primacy” of NCC-derived ectomesenchymal pericytes over mesoderm-derived mesenchymal pericytes has emerged from studies using NCC-derived iPSC-pericytes. These cells recapitulate the properties of primary forebrain pericytes and display adaptive mechanisms for maintaining pericyte-endothelial communication signaling and proper blood-brain barrier (BBB) functions [76, 77]. In line with these findings, are the data that show as endothelial cells, ontogenically derived from mesodermal mesenchymal stem cells, appear less efficient than NCC-derived pericytes in generating TNTs, relying instead on secretory granules and extracellular vesicles for long distance communication [54, 63]. This is consistent with the demonstrated capacity of endothelial PDGF to stimulate the formation of pericyte TNTs [32, 78]. The mechanisms enabling NCC-derived pericytes to play a central role in angiogenic events, forming endothelial-pericyte-combined sprouts and guiding TNTs, remain poorly understood. Given that the efficient expansion of capillary networks requires coordinated endothelial proliferation, migration and sprout formation, this study was also aimed to explore potential novel regulatory mechanisms underlying this pericyte-driven mode of vessel growth. Mechanistic insights into the P-TNT-guided mode of vessel growth Non-canonical angiogenic regulators, such as the receptor-type protein-tyrosine kinase c-KIT/CD117 and its ligand SCF, have been shown to increase the complexity of the retinal vascular network. Their effect is mainly exerted through a marked increase in number of branch points and vascular branches and is suppressed by direct silencing of SCF or its receptor c-KIT [50]. In GB, the expression of SCF and c-KIT in neurons and glioma cells supports endothelial chemotaxis/homing and angiogenesis of circulating endothelial progenitors [52, 79]. These latter also show high expression of SCF2 and potent homing and angiogenic capacities, their angiogenic gene expression pattern closely resembling that of umbilical cord blood cells. This observation indicates a possible reactivation of embryonic/fetal mechanisms of neovascularization [80], consistent with the concept of the onco-fetal reprogramming axis in tumor development [2–4]. Therefore, despite the limited therapeutic efficacy of tyrosine kinase inhibitors in c-KIT-positive tumors, a promising strategy may involve targeting c-KIT+ angiogenic cell subsets and SCF/c-KIT-driven neovascularization [80–83]. Although based on observational in situ analyses of SCF and c-KIT immunolocalization, these correlative findings suggest that the SCF/c-KIT axis may contribute to the regulation of the pericyte-TNT-guided mode of vessel sprouting during both developmental neuroangiogenesis in the fetal brain and neoangiogenesis in GB lesions. The novelty of the present observations lies in the evidence that: (i) both c-KIT and SCF are expressed by endothelial cells; (ii) SCF is also expressed by microvascular pericytes; (iii) SCF displays distinct staining patterns among different types of GB microvessels; and (iv) fetal and tumoral endothelial cells differ in the subcellular distribution of c-KIT immunoreactivity. Based on the above points (i-iii), it can be suggested that multiple c-KIT/SCF-based regulatory mechanisms likely contribute to vessel branching and daughter vessel growth during pericyte-driven vessel sprouting. In fetal brain pericytes, the subcellular SCF staining pattern consists of regularly distributed and aligned puncta at the pericyte-endothelial interface, strongly supporting a juxtacrine mechanism in which SCF directly bounds and activates the receptor on the endothelial membrane. Concurrently, endothelial SCF/c-KIT expression supports autocrine/paracrine regulation of c-KIT intracellular signaling, which may suit or be independent from the pericyte juxtacrine loop. Together, this self and non-self SCF/c-KIT may contribute to proliferative and chemotactic endothelial responses in both developmental and tumoral angiogenesis. In fetal brain the activity of the juxtacrine SCF/c-KIT loop may promote proliferation, survival, and migration of endothelial cells, whereas the endothelial autocrine/paracrine SCF loop may prevent c-KIT endocytosis as a self-protecting mechanism [43, 84]. Regarding point (iv), the detection of a dual, membranous and nuclear, c-KIT immunolocalization in fetal brain endothelial cells, but not in GB microvascular endothelium, suggests potentially distinct functional roles of the SCF/c-KIT axis in developmental versus tumoral angiogenesis. Early, controversial immunohistochemical reports of nuclear c-KIT have been supported by more recent evidence [85, 86] showing that several transmembrane tyrosine kinase receptors undergo vesicle-dependent retrograde transport to the nucleus, where they may act as transcriptional regulators. Nuclear c-KIT has been implicated in non-canonical signaling functions, associated with cancer progression, recurrence, and resistance to treatment [87]. Advances in genetic manipulation have further clarify mechanistic aspects of nuclear internalization and non-canonical RTK activity [88]. However, understanding the biological significance of the presence/absence of nuclear c-KIT in fetal versus GB endothelial cells, remains challenging and extends beyond the scope of this study. Conclusions In conclusion, our observations suggest that the SCF/c-KIT signaling pathway may participate in the regulation of the unconventional TNT-pericyte-driven mode of vessel growth. Although correlative in nature, these findings support further investigations aimed at expanding the current understanding of the cellular and molecular mechanisms underlying pathophysiological angiogenesis and suggest the SCF/c-KIT axis as a potential target for innovative anti-angiogenic strategies focused on the angiogenic potential of NCC-derived pericytes [89]. While the role of SCF/c-KIT signaling in canonical endothelial sprouting is well established [50, 52], its possible involvement in TNT-guided neovascularization mediated by pericytes has not previously been emphasized. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Acknowledgements The authors warmly acknowledge the memory of Joan Abbott, whose mentorship and thoughtful discussions greatly shaped this work. Her contribution and spirit will not be forgotten.The authors would like to thank M.V.C. Pragnell, BA, for language help and Alessia Mora for artwork assistance. Author contributions D. V. and M. E. conceived the study. D. V., T. W., R.P., and F. G. supervised the project. A. D., T.A., and M.S. performed methodology development. T. A., M. D. G, A. B., I. DT., and ME performed the investigations. F. G. and. IDT. curated the data. D. V., A. D., F. G, and M. E., and wrote the original draft. DV, R. R., R. P., F. G., and M. E. critically revised and edited the manuscript. All authors read and approved of the final manuscript. Funding The authors declare no financial support was received for the research, authorship, and/or publication of this article. Data availability All data generated or analysed during this study are included in this published article and its supplementary information files. Additional datasets, including raw images and measurement data, are available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of the University of Bari Medical Committee and of the National Health System Ethics Committee of Canton Zurich. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Consent for publication Was obtained from all subjects involved in the study, Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Daniela Virgintino and Antonio d’Amati contributed equally to the work and share first authorship. Francesco Girolamo and Mariella Errede contributed equally to the work and share last authorship. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Data Availability Statement All data generated or analysed during this study are included in this published article and its supplementary information files. Additional datasets, including raw images and measurement data, are available from the corresponding author upon reasonable request.